Advertisement

Topics

GSK hires Calico's Hal Barron to lead R&D with bumper pay package

17:05 EST 8 Nov 2017 | pharmaphorum

GSK has pulled off a major coup, replacing outgoing chief science officer Patrick Vallance with Calico and former Roche/Genentech whizz, Dr Hal Barron with a bumper pay package that could be worth more than that of his new boss, Emma Walmsley. Val...

Original Article: GSK hires Calico's Hal Barron to lead R&D with bumper pay package

NEXT ARTICLE

More From BioPortfolio on "GSK hires Calico's Hal Barron to lead R&D with bumper pay package"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...